rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Cosmos Health Inc.

COSM · Nasdaq

Health CareHealth Care DistributionAbove a falling average

COSM stood above a rising 150-day average in 4 of the last 52 weekly readings, and has been out of that trend for the last 48 weeks. It is 16.8% above that average now. Health Care Distribution: 20% of its 10 stocks in an uptrend (−10 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Above a falling average
Weeks in an uptrend
out for 48
Industry in uptrend
20% -10 in 4 wk
Insider buys, 12 months
$3.2M
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
19 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 4 of 52 weeks.

17 Apr – 16 Oct
1%20%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Health Care Distribution: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$1.4MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months21
Sale orders, 12 months0
Buyers · sellers2 · 0
WhoDidSharesTraded
Grigorios SiokasChief Executive Officerbought349,825at $0.200130 Jul 2026filed 31 Jul 2026
Grigorios SiokasChief Executive Officerbought766,284at $0.182729 Jul 2026filed 30 Jul 2026
Georgios TerzisChief Financial Officerbought168,135at $0.249816 Jun 2026filed 17 Jun 2026
Grigorios SiokasChief Executive Officerbought218,447at $0.20611 Jun 2026filed 12 Jun 2026
Grigorios SiokasChief Executive Officerbought701,447at $0.228110 Jun 2026filed 12 Jun 2026
Grigorios SiokasChief Executive Officerbought388,532at $0.373212 Feb 2026filed 13 Feb 2026
Grigorios SiokasChief Executive Officerbought291,262at $0.41211 Feb 2026filed 12 Feb 2026
Grigorios SiokasChief Executive Officerbought90,325at $0.498223 Jan 2026filed 26 Jan 2026
Grigorios SiokasChief Executive Officerbought353,321at $0.495320 Jan 2026filed 21 Jan 2026
Grigorios SiokasChief Executive Officerbought493,495at $0.445814 Jan 2026filed 15 Jan 2026
Grigorios SiokasChief Executive Officerbought113,185at $0.503612 Jan 2026filed 13 Jan 2026
Grigorios SiokasChief Executive Officerbought156,190at $0.51868 Jan 2026filed 9 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders19+0 on the quarter
New · exited4 · 4
Reported value$390K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
UBS Group AGadded · filed 13 Aug 2026594,462$110K+581,728+4568.3%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026333,842$62K+238,107+248.7%
JANE STREET GROUP, LLCnew · filed 14 Aug 2026289,287$53K+289,287
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026282,094$52K-36,017−11.3%
BlackRock, Inc.unchanged · filed 7 Aug 2026267,797$49K00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026173,966$32K+33,959+24.3%
NORTHERN TRUST CORPadded · filed 13 Aug 202653,887$9,953+33,333+162.2%
STATE STREET CORPunchanged · filed 7 Aug 202645,243$8,35600.0%
Sassicaia Capital Advisers LLCnew · filed 14 Aug 202636,000$6,649+36,000
KESTRA PRIVATE WEALTH SERVICES, LLCnew · filed 28 Jul 202613,000$2,401+13,000
31 Mar 2023 – 30 Jun 2026
101519Mar 23Dec 23Dec 24Sep 25Jun 26

News

Everyone who traded it

Grigorios Siokas Company insiderChief Executive Officer · last 30 Jul 202661 · 35
Georgios Terzis Company insiderChief Financial Officer · last 29 Jul 20262 · 0
Anastasios Aslidis Company insiderDirector · last 19 May 20260 · 0
Demetrios G. Demetriades Company insiderSecretary · last 19 May 20260 · 0
John James Hoidas Company insiderDirector · last 19 May 20261 · 2
Suhel Bhutawala Company insiderDirector · last 19 May 20260 · 0
Theodoros Christos Karkantzos Company insiderDirector · last 19 May 20260 · 0
Manfred Ziegler Company insiderDirector · last 19 Sep 20240 · 0
Nikolaos Bardakis Company insiderChief Operating Officer · last 19 Sep 20240 · 0
Pavlos Ignatiades Company insiderChief Communications Officer · last 3 Apr 20230 · 0
Peter Goldstein Company insiderDirector, 10% owner · last 20 Jul 20211 · 0
Dimitrios Goulielmos Company insiderChief Executive Officer · last 4 Nov 20150 · 1

Same industry

MCK McKessonAbove a falling average+19%
COR CencoraAbove a falling average+12%
HLF HerbalifeAbove a falling average+11%
NUS Nu Skin EnterprisesNot moving yet-10%
ZSTK ZeroStackNot moving yet-11%
MEDS DataMeds AINot moving yet-31%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202512.1%
Operating profit marginFY 2025 · to 31 Dec 2025-25.6%
Free cash flow marginFY 2025 · to 31 Dec 2025-13.0%
Return on capital employedFY 2025 · to 31 Dec 2025-61.4%
Debt to equityFY 2025 · to 31 Dec 20250.20×
Interest coverFY 2025 · to 31 Dec 2025-8.79×
Research spendFY 2025 · to 31 Dec 20250.8%
Share count trendFY 2025 · to 14 Apr 202623.8%
Cash and equivalentsFY 2025 · to 31 Dec 2025$716K
Free cash flowFY 2025 · to 31 Dec 2025−$8.5M

Analyst forecasts

No analyst forecasts yet.